{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T02:38:09Z","timestamp":1773887889368,"version":"3.50.1"},"reference-count":25,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["DDDT"],"DOI":"10.2147\/dddt.s433377","type":"journal-article","created":{"date-parts":[[2024,5,29]],"date-time":"2024-05-29T03:05:09Z","timestamp":1716951909000},"page":"1855-1864","source":"Crossref","is-referenced-by-count":3,"title":["Evaluation of Drug-Drug Interaction Between Henagliflozin and Hydrochlorothiazide in Healthy Chinese Volunteers"],"prefix":"10.2147","volume":"Volume 18","author":[{"given":"Qian","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengyin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingqing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ye","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0883-8345","authenticated-orcid":true,"given":"Sheng","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2492-3219","authenticated-orcid":true,"given":"Jingying","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2024,5]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1111\/ijcp.12675","volume":"69","author":"Brunton","year":"2015","journal-title":"Int J Clin Pract"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/nrd3180","volume":"9","author":"Chao","year":"2010","journal-title":"Nat Rev Drug Discov"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1042\/CS20171298","volume":"132","author":"Nespoux","year":"2018","journal-title":"Clin Sci"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1002\/ejhf.1170","volume":"20","author":"Seferovi\u0107","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"172845","DOI":"10.1016\/j.ejphar","volume":"867","author":"Zafar","year":"2020","journal-title":"Eur J Pharmacol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s13300-016-0163-1","volume":"7","author":"Leiter","year":"2016","journal-title":"Diabetes Ther"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1111\/ijcp.12675","volume":"38","author":"Kohler","year":"2016","journal-title":"Clin Ther"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1007\/s00125-022-05787-2","volume":"65","author":"Davies","year":"2022","journal-title":"Diabetologia"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"American Diabetes Association Professional Practice Committee. 10 Cardiovascular disease and risk management: standards of medical care in diabetes-2022. Diabetes Care. 2022;45(Suppl 1):S144\u2013S174. doi:10.2337\/dc22-S010","DOI":"10.2337\/dc22-S010"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"American Diabetes Association Professional Practice Committee. 9 Pharmacologic approaches to glycemic treatment: standards of medical care in diabetes-2022. Diabetes Care. 2022;45(Suppl 1):S125\u2013S143. doi:10.2337\/dc22-S009","DOI":"10.2337\/dc22-S009"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"American Diabetes Association Professional Practice Committee. 6 Glycemic targets: standards of medical care in diabetes-2022. Diabetes Care. 2022;45(Suppl 1):S83\u2013S96. doi:10.2337\/dc22-S006","DOI":"10.2337\/dc22-S006"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/S2213-8587(20)30343-0","volume":"9","author":"Marx","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1111\/jch.12597","volume":"19","author":"Epstein","year":"1992","journal-title":"Hypertension"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12933-016-0485-3","volume":"16","author":"Grossman","year":"2017","journal-title":"Cardiovasc Diabetol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1161\/HYP.0000000000000066","volume":"71","author":"Whelton","year":"2018","journal-title":"Hypertension"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1001\/jama.2022.19590","volume":"328","author":"Carey","year":"2022","journal-title":"JAMA"},{"key":"ref17","unstructured":"National Medical Products Administration of China. Technical guideline for clinical pharmacokinetics of chemical drugs [in Chinese]. Available from: https:\/\/www.nmpa.gov.cn\/wwwroot\/gsz05106\/07.pdf. Accessed March 11, 2024."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/ncpendmet0638","volume":"3","author":"Lago","year":"2007","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1210\/er.2010-0029","volume":"32","author":"Abdul-Ghani","year":"2011","journal-title":"Endocr Rev"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/j.1463-1326.2011.01511.x","volume":"14","author":"Defronzo","year":"2012","journal-title":"Diabetes Obes Metab"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1111\/j.1472-8206.2011.01012.x","volume":"26","author":"Ali","year":"2012","journal-title":"Fundam Clin Pharmacol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.clinthera.2020.12.012","volume":"43","author":"Zhang","year":"2021","journal-title":"Clin Ther"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s40261-015-0366-7","volume":"36","author":"Yong","year":"2016","journal-title":"Clin Drug Investig"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"e264","DOI":"10.1016\/j.clinthera.2021.07.008","volume":"43","author":"Chen","year":"2021","journal-title":"Clin Ther"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"703","DOI":"10.3109\/00498254.2015.1113576","volume":"46","author":"Wang","year":"2016","journal-title":"Xenobiotica"}],"container-title":["Drug Design, Development and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=99525","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=99525","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,29]],"date-time":"2024-05-29T03:05:15Z","timestamp":1716951915000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/evaluation-of-drug-drug-interaction-between-henagliflozin-and-hydrochl-peer-reviewed-fulltext-article-DDDT"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":25,"URL":"https:\/\/doi.org\/10.2147\/dddt.s433377","relation":{},"ISSN":["1177-8881"],"issn-type":[{"value":"1177-8881","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5]]}}}